However, studies show that GLP-1 patients who start at lower doses are less likely to experience nausea and are far less likely to quit their program due to side effects
GLP-1RAs are essential for preventing fractures in people with T2DM because they greatly increase bone mass, trabecular and cortical architecture, and total bone strength
Mollica MP, Iossa S, Soboll S, Liverini G (2001) Acetyl-L-carnitine treatment stimulates oxygen consumption and biosynthetic function in perfused liver of young and old rats
No increase in major adverse cardiovascular events occurred during clinical trials, though long-term cardiovascular outcomes trials are ongoing to definitively establish cardiovascular safety and potential benefits
The most common side effects are gastrointestinal side effects such as nausea, vomiting, diarrhea, abdominal pain, decreased appetite, constipation, and injection site reactions
Mallick B, Shrama DJ, Siddappa P, et al